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Purpose: Pathologic changes in the growth plate remain unknown in Legg-Calvé-
Perthes (LCP) disease. Spontaneously hypertensive rats have proven to be a good 
model for studying LCP disease. This study investigated the histopathologic 
changes and the expression of vascular endothelial growth factor in the growth 
plate of spontaneously hypertensive rats (SHR). Materials and Methods: Sixty 
SHR rats were divided into two groups: those showing osteonecrosis (SHR+n 
group: 32), and those showing normal ossification (SHR-n group: 28). Thirty Wis-
ter Kyoto rats served as a control. For histomorphological measurement, the length 
of each zone of the growth plate was measured. Cell kinetics was measured by 
5-bromo-2’-deoxyuridin (BrdU) immunohistochemistry and transferase-mediated 
deoxyuridine triphosphate-biotin nick end labeling (TUNEL) assays. Vascular en-
dothelial growth factor (VEGF) immunohistochemistry was used to identify of ex-
pression of VEGF. Results: The lengths of growth plates of the SHR+n group 
were significantly shorter in the initial growth period than those of the other 
groups. The lowest proliferative rate and the highest apoptosis rate were observed 
in the SHR+n group at the initial growth period. The expression of VEGF in the 
growth plate of the SHR group was lower than the control group, and it was lower 
in the SHR+n group than in the SHR-n group. Conclusion: The growth plate of 
the SHR+n group was found to be affected by disease process of ischemic necro-
sis of the femoral head, and this might explain the relative overgrowth of the great-
er trochanter in the later stages of LCP disease.
Key Words:   Spontaneous hypertensive rats, growth plate, avascular necrosis, 
apoptosis, vascular endothelial growth factor
INTRODUCTION
Legg-Calvé-Perthes (LCP) disease is a pediatric illness characterized by avascular 
necrosis in the immature capital femoral epiphysis of the femoral head.1-3 Contrary to 
avascular necrosis in the femoral head in adults, LCP disease is accompanied by a 
remodeling procedure during its natural course. During the remodeling process, dead 
bone is replaced with living bone, and the deformed head can remodel.4-6 In approxi-
mately 40% of pediatric patients, even if properly treated, the length of the femoral 
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We hypothesized that in addition to the epiphysis, the 
growth plate of the femoral head might be also affected in 
LCP disease. We investigated pathologic changes within 
the growth plate of a SHR model using histological meth-
ods and cellular kinetics. We also investigated the expres-
sion of vascular endothelial growth factor (VEGF) in the 
growth plate of the femoral head to deduce the etiology of 
the femoral head in LCP disease.
MATERIALS AND METHODS
　　　
Experimental animals
The experimental group comprised 12 SHRs for each of the 
6, 9, 12, 15, and 18-week-old groups, for a total of 60 ani-
mals. These were complimented by six age-matched Whister 
Kyoto rats (WKY) in each group, for a total of 30 control 
group animals. Experimental animals were sacrificed under 
ether inhalation anesthesia. The femoral head was exposed 
carefully and the head was extracted from the femoral neck 
by osteotomy using the Smith-Peterson approach. The ex-
tracted tissues were fixed in 4% paraformaldehyde, decalci-
fied for 2 weeks in 10% ethylenediaminetetracetic acid so-
lution, and embedded in paraffin by a conventional method. 
Four µmm-thick sections centered on the ligamentum teres 
attachment area were cut in the coronal plane, and were 
fixed using silane coating slides. Then, they were stained 
with hematoxylin and eosin, and examined under a light 
microscope. Osteonecrosis was observed in 32 (53%) of 
the SHRs, and there were 5-7 rats in each of the age groups, 
respectively. The cases showing growth impairment and 
necrosis in the epiphysis were assigned to the SHR+n 
group, and the cases showing normal ossification were as-
signed to the SHR-n group.
Histomorphological measurements 
The length of the entire growth plate and the length of the 
resting zone, the proliferation zone, and the hypertrophic 
zone were measured separately using the ImagePro® pro-
gram. For all histological examinations, four areas were se-
lected from an identical region of the growth plate where 
necrosis in the epiphysis was detected. The entire length of 
these areas was measured vertically (Fig. 1).
BrdU immunohistochemistry
5-bromo-2’-deoxyuridin (BrdU) was thawed in phosphate 
buffered saline (PBS) and injected peritoneally (100 mg/
neck becomes short after the completion of growth, and 
limping can occur because of the relative overgrowth of the 
greater trochanter area.2,4
Even if the necrotic femoral head is reduced into the ace-
tabulum socket by surgical or non-surgical treatment, per-
sistent residual deformity occurs quite commonly, which 
results in a deformed head and subsequent early degenera-
tive arthritis of the hip joint. Ponseti, et al.1 reported cleft 
formation with amorphous debris in the growth plate ac-
companying amorphous residue and extravasations. They 
observed that cartilage cells continued to proliferate while 
ossification within the cartilage did not occur. This implies 
that avascular necrosis in LCP disease is not simply limited 
to the epiphysis of the femoral head, but also simultaneous-
ly extends to the growth plate.
Histopathological changes in LCP disease have been in-
vestigated by autopsy, and attempts have been made to in-
duce the excessive abduction of the hip joint of piglets. Li-
gation of the blood vessels in the femoral neck has also 
been attempted.7 However, these methods artificially block 
the blood supply to the femoral head and thus induce se-
vere ischemia in the entire femoral head. This can lead to 
irreversible changes, contradicting the so-called “reversibil-
ity” of LCP disease.
In our study, spontaneously hypertensive rats (SHR) were 
used as an animal model of necrosis of the growth plate; 
these rats were obtained by inbreeding rats with spontane-
ous hypertension. These rats are able to develop ischemic 
changes in femoral heads as well as necrosis in the epiphy-
sis during bone maturation, and heal spontaneously with 
aging. Approximately 50% of SHRs suffer a spontaneous 
ischemic insult and subsequent osteonecrosis of the femoral 
head epiphysis around 6-9 weeks of age.8 Therefore, they 
have proven to be a good experimental animal model for 
LCP disease.9,10 
Fig. 1. Measurement of the length of the growth plate using an image ana-
lyzer (×100). L1, L5, L9, L13: total length; L2, L6, L10, L14: resting zone; L3, L7, 
L9, L15: proliferation zone; L4, L8, L12, L16: hypertrophic zone.
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staining cells, three areas of each slide were selected ran-
domly, and the number of total cells and the number of 
stained cells in a rectangle of 150×250 µm in size were as-
sessed. The ratio of positive cells in each zone of the growth 
plate was calculated as the number of positive cells to the 
total number of cells.
VEGF immunohistochemistry
Slides were prepared by a conventional method, treated with 
3% hydrogen peroxide (H2O2), and then treated with 0.4% 
pepsin for 20 minutes. After washing with PBS, 20% goat 
serum was added to the samples, followed by VEGF anti-
body (DAKO) at room temperature for 12 hours. After 
washing with PBS, immunohistochemical staining was per-
formed by applying avidin-biotin (mouse IgG, extra avidin 
method), staining with D DAB, and counter-staining with 
Mayer’s hematoxylin. To count the number of VEGF posi-
tive-staining cells, three areas of each slide were selected 
randomly, and the number of total cells and the number of 
stained cells in a rectangle of 150×250 µm in size were as-
sessed. The ratio of positive cells in each zone of the growth 
plate was calculated as the number of positive cells to the to-
tal number of cells.
Statistical analysis
For all groups, the significance of differences in the entire 
length of the growth plate, the resting zone, the prolifera-
tion zone, and the hypertrophic zone, as well as the number 
of BrdU, TUNNEL, and VEGF positive-staining cells was 
assessed using two-way ANOVA. The level of statistical 
significance was set at p<0.01.
 
RESULTS
 
The growth plate and the length of each zone according 
to age
The length of the growth plate was examined in rats from 6 
weeks to 18 weeks old. We found that the length of the en-
tire growth plate decreased with aging. During the initial pe-
riod of growth at 6 and 9 weeks, a significant difference in 
length of the growth plate was detected when comparing 
WKY, SHR-n, and SHR+n rats. Especially at 6 weeks, the 
length of the entire growth plate of the SHR+n group was 
significantly shorter than that of the WKY group and the 
SHR-n group; it was approximately 63% of that of the WKY 
group. However, as bone growth progressed over time, all 
kg) into experimental animals twice, at 25 hours and 1 hour 
prior to their sacrifice. The slides prepared by a convention-
al method were treated three times with xylen for 10 min-
utes, and for rehydration, the samples were washed with 
100, 90, 70% ethanol and double distilled water sequential-
ly. Endogenous tissue peroxidase was inactivated with 3% 
hydrogen peroxide (H2O2), and tissues were treated with 
0.4% pepsin for 20 minutes. The samples were denatured 
with 2N HCl for 30 minutes, and 20% goat serum was add-
ed to the samples, followed by BrdU primary antibody 
(SIGMA, St. Louis, MO, USA) at room temperature for 12 
hours. Immunohistochemical staining was performed by ap-
plying Avidin-biotin (mouse IgG, extra avidin method), and 
the samples were then washed with PBS, stained with D 
3,3’-diaminobenzidine (DAB), and counter-stained with 
Mayer’s hematoxylin. To count the number of BrdU posi-
tive-staining cells, three areas of each slide were selected 
randomly, and the number of total cells and the number of 
stained cells in a rectangle of 150×250 µm in size were as-
sessed. The ratio of positive cells in each zone of the growth 
plate was calculated as the number of positive cells to the 
total number of cells.
TUNEL assay
Each tissue slide was pre-treated in Tris-HCl solution (pH 
8.0) for 10 minutes and treated with proteinase K for 20 
minutes. After washing with PBS, endogenous tissue per-
oxidase was inactivated with 3% H2O2, and the samples 
were washed again with PBS. The positive control group 
for immunohistochemical examination was pre-treated with 
DNA buffer for 10 minutes and DNA was fragmented arti-
ficially by addition of DNase I for 20 minutes. The samples 
were pre-treated with transferase-mediated deoxyuridin tri-
phosphate buffer (TdT, SIGMA, St. Louis, MO, USA) for 
15 minutes, and reacted with terminaldeoxytransferase and 
Biotin-16-2’-deoxy-uridine-5’-triphosphate (dUTP, F. Hoff-
mann-La Roche Ltd, Basel, Switzerland) at 37°C for 2 
hours 30 minutes to label dUTP. The negative control group 
was not treated with terminaldeoxytransferase. The reaction 
was terminated by immersing the samples in TB buffer for 
10 minutes, and subsequently blocked with 2% Bovine se-
rum albumin for 15 minutes, followed by washing them 
with PBS, reacting them with streptavidin-peroxidase for 
30 minutes, and then staining them with DAB. Nuclear fast 
red was used for counter-staining, and the samples were de-
hydrated again with 70, 90, and 100% ethyl alcohol, and 
then mounted. To count the number of TUNEL positive-
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three groups showed decreases in the lengths of the growth 
plate, and the difference in the lengths of the growth plate 
among the three groups decreased in comparison with the 
initial growth period (Fig. 2).
At 6 weeks of age, the length of the proliferation zone in 
the growth plate of the SHR+n group was significantly short-
er than that of the WKY and SHR-n groups. At 9 weeks of 
age, the length of the resting zone in the growth plate of the 
SHR+n group was significantly shorter than that of the WKY 
and SHR-n groups. The difference in lengths between groups 
at 6 weeks of age was greater than that observed at 9 weeks 
of age (Table 1). 
Measurement of cell proliferation capacity
BrdU positive-staining cells were detected in the hypertro-
Fig. 2. Measurement of the length of the growth plate according to age 
(*p<0.01). WKY, Wister-Kyoto rat; SHR-n, SHR without evidence of isch-
emic necrosis of the epiphysis; SHR+n, SHR with evidence of ischemic ne-
crosis of the epiphysis.
Fig. 3. Findings of BrdU immunohistochemistry (×100). (A) 9 weeks WKY, (B) 9 weeks SHR-n, (C) 9 weeks SHR+n.
Table 1. Measurement of Length of the Growth Plate according to Age
Total length Resting zone Proliferation zone Hypertrophic zone
  6 wks
WKY   329.34±27.39     75.62±13.49 130.32±19.75 106.03±12.97
SHR-n   256.68±22.97     71.87±12.38 102.71±15.10   83.42±12.13
SHR+n     195.31±29.51*     56.26±10.17     64.04±13.49*   61.96±13.94
  9 wks
WKY   215.17±15.81     67.71±12.12 77.59±8.24   75.71±11.04
SHR-n   189.80±18.13   51.37±9.39   73.20±13.66 68.17±12.3
SHR+n     172.36±16.23*     35.25±6.89*   62.79±12.21 64.74±9.91
12 wks
WKY   194.03±11.22   45.74±7.08 71.73±9.40   69.16±13.17
SHR-n   164.48±19.96   31.67±5.71 62.56±8.99   65.14±13.57
SHR+n   146.69±15.76 29.32±4.4 58.33±9.17   56.71±11.29
15 wks
WKY   149.72±20.05   28.76±8.29   54.79±11.14   76.09±11.38
SHR-n   168.87±14.53   25.31±5.81 66.86±9.16   77.99±10.04
SHR+n   126.71±14.89   17.04±3.24 41.39±9.12   56.02±12.65
18 wks
WKY   160.22±16.18   27.05±5.38 52.03±9.59   79.97±11.96
SHR-n 167.27±9.73     21.6±4.06   50.6±7.67 100.41±12.24
SHR+n   113.60±10.68   18.24±3.77 33.35±5.86   62.98±10.71
WKY, Wister-Kyoto rat; SHR-n, SHR without evidence of ischemic necrosis of the epiphysis; SHR+n, SHR with evidence of ischemic necrosis of the epiphysis.
*p<0.01.
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after 12 weeks of age. 
The expression of vascular endothelial growth factor
We found that the expression level of VEGF in each zone in 
all three groups decreased gradually with aging (Fig. 6). In 
the growth plate of the normal WKY control group, cartilage 
cells showed the characteristic longitudinal columnar pattern, 
and this pattern was maintained throughout aging. VEGF 
was expressed in the lower hypertrophic zone and the calcifi-
cation zone of the bone growth plate, and it was also ex-
pressed in the resting zone and the proliferation zone, though 
phic zone (Fig. 3). At 6 and 9 weeks of age, a significant 
difference in cellular proliferation was detected when com-
paring WKY, SHR-n, and SHR+n rats. The WKY group 
had the highest proliferation rate, while the SHR+n group 
had the lowest proliferation rate. However, as bone growth 
progressed over time, all three groups showed a decrease in 
cell proliferation capacity, and the difference in cell prolif-
eration capacity among the three groups decreased in com-
parison with the initial growth period; by the age of 12 
weeks, there was no significant difference between the 
lengths of the growth plate in the three groups (Table 2). 
Measurement of the rate of apoptosis
We found that the rate of apoptosis increased with aging 
(Fig. 4). The rate of apoptosis in all three groups was over 
20% after 12 weeks of age. At 6 and 9 weeks of age, a signif-
icant difference in the rate of apoptosis was detected when 
comparing WKY, SHR-n, and SHR+n rats. At 6 weeks of 
age, the rate of apoptosis in the resting zone of the SHR+n 
group was significantly higher than that of the WKY and 
SHR-n groups. At 9 weeks of age, the rate of apoptosis in 
the proliferation zone of the SHR+n group was significant-
ly higher than that of the WKY and SHR-n group (Fig. 5). 
At 18 weeks of age, the rate of apoptosis in the SHR+n 
group was higher than that of other groups (Table 3). How-
ever, there was no significant difference among three groups 
Fig. 4. Comparison of apoptosis between groups (*p<0.01). WKY, Wister-
Kyoto rat; SHR-n, SHR without evidence of ischemic necrosis of the epiph-
ysis; SHR+n: SHR, with evidence of ischemic necrosis of the epiphysis.
Fig. 5. Findings of apoptosis (×100, TUNEL assay). (A) 9 weeks WKY, (B) 9 weeks SHR-n, (C) 9 weeks SHR+n.
A B C
Table 2. Comparison of Cellular Proliferation between Groups
6 wks 9 wks 12 wks 15 wks 18 wks
WKY 23.2±4.8 19.9±2.4 15.2±5.5 12.6±9.6 12.0±5.8
Proliferation zone   SHR-n 20.7±6.4 19.0±7.9 15.3±5.2 11.7±8.4 11.5±6.7
  SHR+n   16.8±7.1*   13.4±5.7* 10.1±4.3   8.8±4.9     9.1±10.7
WKY, Wister-Kyoto rat; SHR-n, SHR without evidence of ischemic necrosis of the epiphysis; SHR+n, SHR with evidence of ischemic necrosis of the epiphysis.
*p<0.01.
0
10
20
30
40
50
Ce
ll p
ro
lif
er
at
io
n 
pe
rc
en
t (
%
)
6 w 9 w 12 w 15 w 18 w
Time (weeks)
*
*
WKY
SHR-n
SHR+n
(unit: µm)
Hoon Park, et al.
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012630
lumnar cells exhibited an island pattern, and the expression 
of VEGF was significantly reduced at 6 and 9 weeks com-
pared to the other two groups. As the age of the rats in-
creased to 12 weeks and 15 weeks, the expression of VEGF 
decreased, but there was no significant difference among 
the three groups (Table 4).
DISCUSSION
In the growth plate, four types of histologically distinguish-
able chondrocytes form a continuous columnar pattern.11 
Chondrocytes in the resting zone are inactive flat cells that 
supply new cells for the proliferation of cartilage cells. Cells 
in the proliferation zone repeat cell division and mature to a 
round shape, increasing cell volumes to create a vertical 
space. These cells also produce extracellular matrix so that 
the distance between cells is expanded and progresses to 
the hypertrophic zone. In the hypertrophic zone, the accu-
to a lesser extent (Fig. 7). In the SHR-n group, the character-
istic longitudinal columnar pattern of the growth plate was 
maintained; however, the level of expression of VEGF was 
lower than that of the WKY group. In the SHR+n group, co-
Table 3. Comparison of Apoptosis between Groups
Total  length Resting zone Proliferation zone Hypertrophic zone
  6 wks
WKY   15.37±3.85   9.92±5.90   17.37±4.78   14.3±4.61
SHR-n   17.18±6.32 13.72±9.08   16.02±6.40 18.23±5.94
SHR+n     24.24±7.53*       16.1±14.69*   20.97±9.10 28.27±8.94
  9 wks
WKY   19.44±4.83 28.49±4.96     5.81±2.43 24.1±7.3
SHR-n   20.89±6.07 26.09±7.11   22.08±9.97 16.48±3.72
SHR+n   26.66±6.2*   44.34±11.74     22.32±8.69* 28.15±9.26
12 wks
WKY   20.92±5.17   23.92±12.04   24.61±5.49 19.08±8.68
SHR-n   30.26±5.97   33.15±12.06   25.39±5.21 33.71±5.84
SHR+n   21.01±6.57 47.72±10.3   33.03±4.34 25.11±7.75
15 wks
WKY   20.44±3.98 29.84±8.43     6.39±9.56 26.27±4.91
SHR-n   32.11±5.87 43.24±9.82 25.71±8.4     29.5±10.72
SHR+n 29.25±7.7   31.32±11.64     33.88±16.89 31.59±8.37
18 wks
WKY   23.76±4.74 42.23±8.94   12.03±5.77 26.45±6.58
SHR-n   34.69±8.87 45.42±4.62   14.51±6.73   44.58±12.25
SHR+n     42.9±7.74   49.6±7.75     31.19±11.74   47.75±20.91
WKY, Wister-Kyoto rat; SHR-n, SHR without evidence of ischemic necrosis of the epiphysis; SHR+n, SHR with evidence of ischemic necrosis of the epiphysis.
*p<0.01.
Fig. 7. Findings of VEGF expression in the growth plate of the WKY group (×200). (A) 9 weeks, (B) 12 weeks, (C) 15 weeks. VEGF, vascular endothelial growth 
factor.
A B C
(unit: µm)
Fig. 6. Comparison of VEGF expression between groups (*p<0.01). WKY, 
Wister-Kyoto rat; SHR-n, SHR without evidence of ischemic necrosis of the 
epiphysis; SHR+n, SHR with evidence of ischemic necrosis of the epiphysis; 
VEGF, vascular endothelial growth factor.
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the SHR+n group over time. 
The length of the entire growth plate of the SHR-n group 
was longer than that of the WKY group because of an in-
crease in the length of the hypertrophic zone in the SHR-n 
group. Similarly, in the WKY group, an increase in the length 
of the hypertrophic zone was detected from 15 weeks, 
though the increase in length of the hypertrophic zone was 
larger in the SHR-n group than in the WKY group. A previ-
ous study reported that the length of the hypertrophic zone 
was proportional to the growth rate of the growth plate. In 
our study, we conjectured, due to the delay of angiogenesis 
of the neovasculature and blood supply from the metaphy-
sis, the influx of ossification-induction materials and osteo-
blasts were decreased and bone cells were not able to sub-
stitute for cartilage cells, resulting in an increase in length 
of the growth plate. In contrast, in the SHR+n group, as the 
length of the growth plate increased from 18 weeks of age, 
it was most likely due to ischemic change during the early 
growth period.
We suspected that the larger growth delay of the SHR+n 
group compared to the others was due to a lower rate of cell 
proliferation in the SHR+n group. Particularly, in the early 
growth periods, the rates of cell proliferation in the resting 
zone and proliferation zone of the SHR+n group were sig-
nificantly lower than those in the WKY and SHR-n groups.
Apoptosis in the growth plate occurs during substitution 
of the lower hypertrophic zone with bone.19 However, apop-
tosis in the growth plate may also occur as a result of injury 
to the growth plate caused by necrosis in the epiphysis.20 At 
6 weeks of age, a rate of apoptosis of 15-24% was observed 
for all groups, and there were no significant differences be-
tween groups. However, when each zone was examined 
separately, a significant difference in the resting zone at 6 
weeks and the proliferation zone at 9 weeks was observed 
between the two SHR groups and the WKY group. At 18 
weeks of age, the apoptosis rate of the growth plate was ap-
proximately 47.8% in the SHR+n group, which was almost 
twice the 23.7% apoptosis rate of the WKY group. We 
speculated that normal apoptosis, which substitutes carti-
mulation and release of calcium in chondrocytes and the 
calcification of the stroma are achieved. Simultaneously, 
the neovasculature is infiltrated from the metaphysis, and 
then cells required for bone formation, including osteogenic 
precursor cells and chondroclasts are influxed. Together 
with the infiltration of these cells, while undergoing the 
apoptosis process and transforming to bone, the growth of 
length was occurred.12-17 
VEGF, along with Indian hedgehog, parathyroid hor-
mone related protein, bone morphogenetic protein, matrix 
metalloproteinase (MMP), and type X collagen, has been 
reported to play a major role in endochondral ossifica-
tion.7,9,12,13 VEGF is produced in cartilage cells in the hyper-
trophic zone and the calcification zone, and VEGF recep-
tors are expressed on vascular endothelial cells as well as 
on osteoclasts and osteoblasts. To assess the function of 
VEGF in cartilage ossification, Gerber, et al.18 blocked the 
function of VEGF with soluble receptor chimeric protein 
[Flt-(1-3)-IgG] and examined histological changes in the 
cartilage thereafter. They found, as a result, that there was 
no influx of blood vessels, and formation of reticular bones 
was suppressed. Furthermore, widening of the hypertrophic 
zone, suppression of the infiltration and differentiation of 
osteoclasts, and reduction of cartilage cell absorption were 
observed. They confirmed that VEGF-controlled invasion 
of neovasculature was essential for cartilage ossification and 
remodeling. 
In our study, in the early growth periods of 6 and 9 weeks 
of age, the whole and partial length of the growth plate of 
the SHR+n group was significantly different from that of the 
WKY group and the SHR-n group, and growth impairment 
was noticeable in the proliferation zone during the early 
growth period at 6 weeks and in the resting zone at 9 weeks. 
At 15 and 18 weeks, the length of the entire growth plate of 
the SHR+n group was the shortest among the three groups. 
However, the difference in the length of the growth plate 
between the groups was smaller at 15 and 18 weeks than at 
6 and 9 weeks, we thought that these results were most 
likely due to spontaneous recovery of the growth plate in 
Table 4. Comparison of VEGF Expression between Groups
6 wks 9 wks 12 wks 15 wks
WKY   58.90±11.07 53.91±12.51 38.59±13.22   25.95±12.11
SHR-n 52.55±11.5 47.07±12.84 35.91±10.60   24.64±12.27
SHR+n   35.15±8.66*   27.16±10.97* 23.71±11.04 16.27±4.17
WKY, Wister-Kyoto rat; SHR-n, SHR without evidence of ischemic necrosis of the epiphysis; SHR+n, SHR with evidence of ischemic necrosis of the epiphy-
sis; VEGF, vascular endothelial growth factor.
*p<0.01.
(unit: µm)
Hoon Park, et al.
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012632
Affairs, Republic of Korea (#A084120).
REFERENCES
1. Ponseti IV, Maynard JA, Weinstein SL, Ippolito EG, Pous JG. 
Legg-Calvé-Perthes disease. Histochemical and ultrastructural ob-
servations of the epiphyseal cartilage and physis. J Bone Joint 
Surg Am 1983;65:797-807.
2. Schoenecker PL, Stone JW, Capelli AM. Legg-Perthes disease in 
children under 6 years old. Orthop Rev 1993;22:201-8.
3. Oda J, Hirano T, Iwasaki K, Majima R. Vascular occlusion and 
cartilage disorders in osteonecrosis of the femoral head in rats. Int 
Orthop 1996;20:185-9.
4. Kim HT, Wenger DR. “Functional retroversion” of the femoral 
head in Legg-Calvé-Perthes disease and epiphyseal dysplasia: 
analysis of head-neck deformity and its effect on limb position us-
ing three-dimensional computed tomography. J Pediatr Orthop 
1997;17:240-6.
5. Zenmyo M, Komiya S, Kawabata R, Sasaguri Y, Inoue A, Mori-
matsu M. Morphological and biochemical evidence for apoptosis 
in the terminal hypertrophic chondrocytes of the growth plate. J 
Pathol 1996;180:430-3.
6. Kong SY, Kim HW, Park HW, Lee SY, Lee KS. Effects of multi-
ple drilling on the ischemic capital femoral epiphysis of immature 
piglets. Yonsei Med J 2011;52:809-17.
7. Kim HK, Su PH, Qiu YS. Histopathologic changes in growth-
plate cartilage following ischemic necrosis of the capital femoral 
epiphysis. An experimental investigation in immature pigs. J Bone 
Joint Surg Am 2001;83-A:688-97.
8. Little DG, McDonald M, Sharpe IT, Peat R, Williams P, McEvoy 
T. Zoledronic acid improves femoral head sphericity in a rat mod-
el of perthes disease. J Orthop Res 2005;23:862-8.
9. Hirano T, Iwasaki K, Oda J, Kumashiro T. Osteonecrosis of the 
femoral head in spontaneously hypertensive rats. Relation to ossif-
ic nuclei during growth. Acta Orthop Scand 1992;63:37-40.
10. Naito S, Ito M, Sekine I, Ito M, Hirano T, Iwasaki K, et al. Femo-
ral head necrosis and osteopenia in stroke-prone spontaneously 
hypertensive rats (SHRSPs). Bone 1993;14:745-53.
11. Kawahara T, Shimokawa I, Tomita M, Hirano T, Shindo H. Ef-
fects of caloric restriction on development of the proximal growth 
plate and metaphysis of the caput femoris in spontaneously hyper-
tensive rats: microscopic and computer-assisted image analyses. 
Microsc Res Tech 2002;59:306-12.
12. Hirano T, Majima R, Yoshida G, Iwasaki K. Characteristics of 
blood vessels feeding the femoral head liable to osteonecrosis in 
spontaneously hypertensive rats. Calcif Tissue Int 1996;58:201-5.
13. Tomita M, Shimokawa I, Maeda H, Higami Y, Kawahara T, Ikeda 
T, et al. Dietary restriction reduces the prevalence of osteonecrosis 
of the caput femoris in spontaneously hypertensive rats. Calcif 
Tissue Int 1999;64:259-62.
14. Maes C, Carmeliet P, Moermans K, Stockmans I, Smets N, Collen 
D, et al. Impaired angiogenesis and endochondral bone formation 
in mice lacking the vascular endothelial growth factor isoforms 
VEGF164 and VEGF188. Mech Dev 2002;111:61-73.
15. Farnum CE, Wilsman NJ. Determination of proliferative charac-
teristics of growth plate chondrocytes by labeling with bromode-
oxyuridine. Calcif Tissue Int 1993;52:110-9.
16. Wilsman NJ, Farnum CE, Green EM, Lieferman EM, Clayton 
lage for bone, and also apoptosis induced by DNA damage 
were responsible for the overall high rate of apoptosis rate 
in the SHR+n group.
In contrast to the rate of apoptosis, we observed that the ex-
pression of VEGF decreased with aging during the normal os-
sification process, which implied that the expression of VEGF 
was dependent upon the growth stage; when growth is over, 
VEGF becomes less important than in the early growth peri-
od. The expression of VEGF in the growth plate was lower in 
the two SHR groups than the control WKY group, and the 
lowest expression level was observed in the SHR+n group. 
The difference of the expression of VEGF in the two SHR 
groups implied that the expression of VEGF was influenced 
by a variety of factors which are not genetically determined. It 
is therefore essential to examine the expression of more fac-
tors such as matrix metalloproteinase-9 (MMP-9) and insulin-
like growth factor-1. The role of VEGF in the infiltration of 
blood vessels should also be studied further assessing the 
RNA and protein levels of this factor.
Our study had several limitations, even though we adjust-
ed for various limitations by incorporating a large number 
of animals in the study. First, to evaluate adverse effects on 
the growth plate, we measured growth plate thickness. This 
is an easy and simple method; however, it may not be a 
sensitive enough indicator for evaluating the function of the 
growth plate. Second, we chose the SHR model for this in-
vestigation as it more closely resembles LCP disease than 
surgically induced models. With the surgically induced 
model it is possible to ascertain the time when the avascular 
necrosis of the femoral head develops, but in our SHR mod-
el we could not determine the onset time of avascular ne-
crosis of the femoral head. 
In conclusion, we were able to observe decreases in the 
length, proliferation rate, and the expression of VEGF, as 
well as an increase in the apoptosis rate of growth plates in 
SHR+n group. The growth plate of the SHR+n group was 
found to be affected by the disease process of ischemic ne-
crosis of the femoral head, and this might explain why a 
round femoral head is frequently associated with relative 
overgrowth of the greater trochanter in the later stages of 
LCP disease.
ACKNOWLEDGEMENTS
This study was supported by the Korea Healthcare technol-
ogy R&D Project, Ministry for Health, Welfare & Family 
Altered Cellular Kinetics in Growth Plate of Femoral Head 
Yonsei Med J   http://www.eymj.org   Volume 53   Number 3   May 2012 633
VEGF couples hypertrophic cartilage remodeling, ossification and 
angiogenesis during endochondral bone formation. Nat Med 
1999;5:623-8.
19. Matsuno T, Ishida O, Arihiro K, Sunagawa T, Mori N, Ikuta Y. 
Cell proliferation and death of growth plate chondrocyte caused 
by ischemia and reperfusion. Microsurgery 2001;21:30-6.
20. Roach HI, Clarke NM. Physiological cell death of chondrocytes 
in vivo is not confined to apoptosis. New observations on the 
mammalian growth plate. J Bone Joint Surg Br 2000;82:601-13.
MK. Cell cycle analysis of proliferative zone chondrocytes in 
growth plates elongating at different rates. J Orthop Res 1996;14: 
562-72.
17. Galotto M, Campanile G, Robino G, Cancedda FD, Bianco P, 
Cancedda R. Hypertrophic chondrocytes undergo further differen-
tiation to osteoblast-like cells and participate in the initial bone 
formation in developing chick embryo. J Bone Miner Res 1994;9: 
1239-49.
18. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. 
